1-Stearoylglycerol is associated with risk of prostate cancer: Results from a serum metabolomic profiling analysis

Metabolomics

Volumn 10, Issue 5, 2014, Pages 1036-1041

  Mondul, Alison M ^a   Moore, Steven C ^a   Weinstein, Stephanie J ^a   Männistö, Satu ^b   Sampson, Joshua N ^a   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Biomarker; Early detection; Metabolomics; Nested case control study; Prospective study; Prostatic neoplasms

Indexed keywords

2 OXOGLUTARIC ACID; 2 OXOISOVALERIC ACID; 3 HYDROXY 2 METHYLPROPIONIC ACID; 5' METHYLTHIOADENOSINE; ALPHA TOCOPHEROL; AZELAIC ACID; BETA CAROTENE; GLYCERIC ACID; GLYCEROL; GLYCEROL STEARATE; GLYCOCHOLIC ACID; LINOLENIC ACID; METHIONINE; MYRISTIC ACID; OLEIC ACID; PALMITOLEIC ACID; PHENYLALANINE; PLACEBO; PROPIONYLCARNITINE; RIBOSE; SPHINGANINE; STEARIC ACID; VALERIC ACID; XANTHINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; PROSTATE CANCER; SMOKING;

EID: 84894695275     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0643-0     Document Type: Article

References (16)

1. Beyoglu, D., et al. (2013). Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology,. doi: 10. 1002/hep. 26350.
2. Brawley, O. W. (2012). Prostate cancer epidemiology in the United States. World Journal of Urology, 30, 195-200. doi: 10. 1007/s00345-012-0824-2.
3. Dehaven, C. D., Evans, A. M., Dai, H., & Lawton, K. A. (2010). Organization of GC/MS and LC/MS metabolomics data into chemical libraries. Journal of Cheminformatics, 2, 9. doi: 10. 1186/1758-2946-2-9.
4. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009). Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical Chemistry, 81, 6656-6667. doi: 10. 1021/ac901536h.
5. Lokhov, P. G., Dashtiev, M. I., Moshkovskii, S. A., & Archakov, A. I. (2010). Metabolite profiling of blood plasma of patients with prostate cancer. Metabolomics, 6, 156-163.
6. Menendez, J. A. (2010). Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives. Biochimica et Biophysica Acta, 1801, 381-391. doi: 10. 1016/j. bbalip. 2009. 09. 005.
7. Moyer, V. A., & Force, U. S. P. S. T. (2012). Screening for prostate cancer: US preventive services task force recommendation statement. Annals of Internal Medicine, 157, 120-134. doi: 10. 7326/0003-4819-157-2-201207170-00459.
8. Nicholson, J. K., & Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455, 1054-1056. doi: 10. 1038/4551054a.
9. Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S. W., & Cravatt, B. F. (2010). Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 140, 49-61. doi: 10. 1016/j. cell. 2009. 11. 027.
10. Nomura, D. K., et al. (2011). Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chemistry & Biology, 18, 846-856. doi: 10. 1016/j. chembiol. 2011. 05. 009.
11. O'Connell, T. M. (2012). Recent advances in metabolomics in oncology. Bioanalysis, 4, 431-451. doi: 10. 4155/bio. 11. 326.
12. Sampson, J. N., et al. (2013). Metabolomics in epidemiology: Sources of variability in metabolite measurements and implications. Cancer Epidemiology, Biomarkers, & Prevention in press,.
13. Sreekumar, A., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457, 910-914. doi: 10. 1038/nature07762.
14. The ATBC Cancer Prevention Study Group. (1994). The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Annals of Epidemiology, 4, 1-10.
15. Thysell, E., et al. (2010). Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS ONE, 5, e14175. doi: 10. 1371/journal. pone. 0014175.
16. Trock, B. J. (2011). Application of metabolomics to prostate cancer. Urologic Oncology, 29, 572-581. doi: 10. 1016/j. urolonc. 2011. 08. 002.